News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Genetics Company, Inc. Raises $21 Million Series C, To Focus On Cancer Therapeutics


10/19/2005 5:12:45 PM

The Genetics Company Inc., a drug and diagnostics company with work in the fields of cancer and Alzheimer's disease, said it closed CHF25 million ($21 million) in a Series C round as it transitions its focus solely to cancer therapeutics.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES